These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 31502378)

  • 1. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
    Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
    J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
    Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
    Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.
    Ribeiro A; Laranjeira P; Mendes S; Velada I; Leite C; Andrade P; Santos F; Henriques A; Grãos M; Cardoso CM; Martinho A; Pais M; da Silva CL; Cabral J; Trindade H; Paiva A
    Stem Cell Res Ther; 2013 Oct; 4(5):125. PubMed ID: 24406104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis.
    Eljaafari A; Tartelin ML; Aissaoui H; Chevrel G; Osta B; Lavocat F; Miossec P
    Arthritis Rheum; 2012 Jul; 64(7):2147-57. PubMed ID: 22275154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis.
    Liu Y; Mu R; Wang S; Long L; Liu X; Li R; Sun J; Guo J; Zhang X; Guo J; Yu P; Li C; Liu X; Huang Z; Wang D; Li H; Gu Z; Liu B; Li Z
    Arthritis Res Ther; 2010; 12(6):R210. PubMed ID: 21080925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
    Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
    Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes.
    Xu K; Ma D; Zhang G; Gao J; Su Y; Liu S; Liu Y; Han J; Tian M; Wei C; Zhang L
    Mol Immunol; 2021 Jul; 135():36-44. PubMed ID: 33857817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer.
    Luz-Crawford P; Hernandez J; Djouad F; Luque-Campos N; Caicedo A; Carrère-Kremer S; Brondello JM; Vignais ML; Pène J; Jorgensen C
    Stem Cell Res Ther; 2019 Aug; 10(1):232. PubMed ID: 31370879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis.
    Zhang Z; Ding Y; Li W; Song B; Yang R
    Arthritis Res Ther; 2013 Oct; 15(5):R169. PubMed ID: 24286220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Check-control of inflammation displayed by bone marrow mesenchymal stem cells in rheumatoid arthritis patients.
    Lamas JR; Mucientes A; Lajas C; Fernández-Gutiérrez B; Lópiz Y; Marco F; Jover JA; Abásolo L; Rodriguez-Rodriguez L
    Immunotherapy; 2019 Sep; 11(13):1107-1116. PubMed ID: 31378114
    [No Abstract]   [Full Text] [Related]  

  • 15. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-146a Improves Immunomodulatory Effects of MSC-derived Exosomes in Rheumatoid Arthritis.
    Tavasolian F; Hosseini AZ; Soudi S; Naderi M
    Curr Gene Ther; 2020; 20(4):297-312. PubMed ID: 32938348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 Cells.
    Wang LT; Jiang SS; Ting CH; Hsu PJ; Chang CC; Sytwu HK; Liu KJ; Yen BL
    Stem Cells; 2018 Jun; 36(6):903-914. PubMed ID: 29396902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of continuous passage on the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells in vitro.
    Connard SS; Linardi RL; Even KM; Berglund AK; Schnabel LV; Ortved KF
    Vet Immunol Immunopathol; 2021 Apr; 234():110203. PubMed ID: 33636546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell source-dependent in vivo immunosuppressive properties of mesenchymal stem cells derived from the bone marrow and synovial fluid of minipigs.
    Lee WJ; Hah YS; Ock SA; Lee JH; Jeon RH; Park JS; Lee SI; Rho NY; Rho GJ; Lee SL
    Exp Cell Res; 2015 May; 333(2):273-288. PubMed ID: 25819273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4
    Massalska M; Radzikowska A; Kuca-Warnawin E; Plebanczyk M; Prochorec-Sobieszek M; Skalska U; Kurowska W; Maldyk P; Kontny E; Gober HJ; Maslinski W
    Cells; 2020 Feb; 9(3):. PubMed ID: 32111105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.